# Selected journal articles

> Menopause Consultants: selected articles — The Menopause Consultants reading list covers postmenopausal estrogen and GH rebound, GHRH analogue pharmacology, cognitive outcomes and safety observations.

**Reading list**

The postmenopausal experiment starts the discussion. The other papers supply the physiology, chemistry and clinical outcomes.

## The estrogen experiment and its neighbours

Begin with [endogenous estrogen and the postmenopausal rebound](https://pubmed.ncbi.nlm.nih.gov/27459535/). The experiments in [older men](https://pubmed.ncbi.nlm.nih.gov/23485864/) and [young men with experimentally induced hypogonadism](https://pubmed.ncbi.nlm.nih.gov/19458139/) examine other hormonal settings.

## From the molecule to measured outcomes

The [tesamorelin review](https://pubmed.ncbi.nlm.nih.gov/22298602/) and [non-clinical pharmacology study](https://pubmed.ncbi.nlm.nih.gov/17214611/) discuss the analogue's design. The [healthy-men experiment](https://pubmed.ncbi.nlm.nih.gov/20943777/) examines hormone responses. The cognitive trials in [older adults](https://pubmed.ncbi.nlm.nih.gov/22869065/) and [people with HIV](https://pubmed.ncbi.nlm.nih.gov/39813152/) ask about cognitive outcomes. The complete list also includes the glucose trial and the review of adverse effects discussed on the site.

## References

[1] Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women. https://pubmed.ncbi.nlm.nih.gov/27459535/
[2] Differential pulsatile secretagogue control of GH secretion in healthy men. https://pubmed.ncbi.nlm.nih.gov/23485864/
[3] Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism. https://pubmed.ncbi.nlm.nih.gov/19458139/
[4] Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy https://pubmed.ncbi.nlm.nih.gov/22298602/
[5] Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. https://pubmed.ncbi.nlm.nih.gov/17214611/
[6] Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men https://pubmed.ncbi.nlm.nih.gov/20943777/
[7] Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial https://pubmed.ncbi.nlm.nih.gov/22869065/
[8] Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity https://pubmed.ncbi.nlm.nih.gov/39813152/
[9] Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial https://pubmed.ncbi.nlm.nih.gov/28617838/
[10] Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. https://pubmed.ncbi.nlm.nih.gov/21265979/

---

At Menopause Consultants I examine what hormonal responses depend on in published research; this essay site is no consulting business, and its discussion provides no medical advice.